Skip to main content
Top
Published in: Sleep and Breathing 4/2015

01-12-2015 | Original Article

Obstructive sleep apnea rather than diabetes or obesity associated with proteinuria in late mid-aged male workers: a decision tree analysis

Authors: Hua Ting, Cher-Ming Liou, Tung-Sheng Shih, Chih-Huan Wang, Shu-Yun Chang, Ai-Hui Chung, Jia-Fei Lee, Lee Wang, Ren-Jing Huang, Shin-Da Lee

Published in: Sleep and Breathing | Issue 4/2015

Login to get access

Abstract

Background

Both proteinuria and obstructive sleep apnea (OSA) are associated with cardiovascular events and consequent mortality. To examine whether age, OSA, diabetes, and obesity are potential predictors of proteinuria, a data-driven analysis was performed to delineate a potential categorical classification algorithm.

Methods

In this cross-sectional community-based cohort study, demographic data, blood pressure, serum biochemical analyses, proteinuria via single dipstick urinalysis, and overnight polysomnographies were measured in 300 males with sedentary work styles.

Results

Sixty-one (20.3 %) of all these participants had proteinuria. Logistic regression analysis showed that glycated hemoglobin (HbA1c), duration of arterial oxygen saturation <90 %, age, and log high-sensitivity C-reactive protein, but not apnea-hypopnea index (AHI), were responsible for 16.7 % of the variance of proteinuria’s presence. A decision tree analysis showed that subjects over 49 years old had a higher risk for proteinuria than those subjects of 49 years old, or less. In the over 49-year-old group, subjects with an AHI >21 events/h had a higher risk for proteinuria; whereas in the 49-year-old and less group, subjects with HbA1c >7 %, or with HbA1c ≤7, and body mass index (BMI) >27.4 kg/m2 had a higher risk for proteinuria than their counterparts.

Conclusions

AHI was the major determinant responsible for the presence of proteinuria in late mid-aged male workers, while HbA1c and BMI were found in the junior subgroup. By algorithmic analysis, this study provides a comprehensive hierarchical model for better understanding of the correlates of proteinuria and sleep apnea.
Literature
1.
go back to reference Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164–176CrossRefPubMed Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164–176CrossRefPubMed
2.
go back to reference Niskanen L, Turpeinen A, Penttila I, Uusitupa MI (1998) Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care 21:1861–1869CrossRefPubMed Niskanen L, Turpeinen A, Penttila I, Uusitupa MI (1998) Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care 21:1861–1869CrossRefPubMed
3.
go back to reference Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626–1634CrossRefPubMed Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626–1634CrossRefPubMed
4.
go back to reference Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Ghione S (1989) Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 2:259–261PubMed Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Ghione S (1989) Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 2:259–261PubMed
5.
go back to reference Shaw J, Hughes CM, Lagan KM, Bell PM, Stevenson MR (2007) An evaluation of three wound measurement techniques in diabetic foot wounds. Diabetes Care 30:2641–2642CrossRefPubMed Shaw J, Hughes CM, Lagan KM, Bell PM, Stevenson MR (2007) An evaluation of three wound measurement techniques in diabetic foot wounds. Diabetes Care 30:2641–2642CrossRefPubMed
6.
go back to reference Sung KC, Kim BJ, Ryu S (2008) An association of a variety of cardiovascular risk factors with low grade albuminuria in Korean men. Atherosclerosis 196:320–326CrossRefPubMed Sung KC, Kim BJ, Ryu S (2008) An association of a variety of cardiovascular risk factors with low grade albuminuria in Korean men. Atherosclerosis 196:320–326CrossRefPubMed
7.
go back to reference Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777–1782CrossRefPubMed Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777–1782CrossRefPubMed
8.
go back to reference Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139:901–906CrossRefPubMed Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139:901–906CrossRefPubMed
9.
go back to reference Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167–174CrossRefPubMed Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167–174CrossRefPubMed
10.
go back to reference Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134CrossRefPubMed Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134CrossRefPubMed
11.
go back to reference Narkiewicz K, Somers VK (1998) Chronic orthostatic intolerance: part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis? Circulation 98:2105–2107CrossRefPubMed Narkiewicz K, Somers VK (1998) Chronic orthostatic intolerance: part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis? Circulation 98:2105–2107CrossRefPubMed
12.
go back to reference Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151–1158CrossRefPubMed Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151–1158CrossRefPubMed
13.
go back to reference Phillips BG, Somers VK (2002) Sleep disordered breathing and risk factors for cardiovascular disease. Curr Opin Pulm Med 8:516–520CrossRefPubMed Phillips BG, Somers VK (2002) Sleep disordered breathing and risk factors for cardiovascular disease. Curr Opin Pulm Med 8:516–520CrossRefPubMed
14.
go back to reference Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384CrossRefPubMed Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384CrossRefPubMed
16.
go back to reference Kinebuchi S, Kazama JJ, Satoh M, Sakai K, Nakayama H, Yoshizawa H, Narita I, Suzuki E, Gejyo F (2004) Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 107:317–322CrossRef Kinebuchi S, Kazama JJ, Satoh M, Sakai K, Nakayama H, Yoshizawa H, Narita I, Suzuki E, Gejyo F (2004) Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 107:317–322CrossRef
17.
go back to reference Buchner NJ, Wissing KR, Stegbauer J, Quack I, Weiner SM, Kramer BK, Rump LC (2011) The renal resistance index is increased in mild-to-moderate obstructive sleep apnoea and is reduced under continuous positive airway pressure. Nephrol Dial Transplant 26:914–920CrossRefPubMed Buchner NJ, Wissing KR, Stegbauer J, Quack I, Weiner SM, Kramer BK, Rump LC (2011) The renal resistance index is increased in mild-to-moderate obstructive sleep apnoea and is reduced under continuous positive airway pressure. Nephrol Dial Transplant 26:914–920CrossRefPubMed
18.
go back to reference Mercado N, Brugts JJ, Ix JH, Shlipak MG, Dixon SR, Gersh BJ, Lemos PA, Guarneri M, Teirstein PS, Wijns W, Serruys PW, Boersma E, O’Neill WW (2008) Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial). Am J Cardiol 102:1151–1155CrossRefPubMed Mercado N, Brugts JJ, Ix JH, Shlipak MG, Dixon SR, Gersh BJ, Lemos PA, Guarneri M, Teirstein PS, Wijns W, Serruys PW, Boersma E, O’Neill WW (2008) Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial). Am J Cardiol 102:1151–1155CrossRefPubMed
19.
go back to reference Ting H, Lo HS, Chang SY, Chung AH, Kuan PC, Yuan SC, Huang CN, Lee SD (2009) Post- to pre-overnight sleep systolic blood pressures are associated with sleep respiratory disturbance, pro-inflammatory state and metabolic situation in patients with sleep-disordered breathing. Sleep Med 10:720–725CrossRefPubMed Ting H, Lo HS, Chang SY, Chung AH, Kuan PC, Yuan SC, Huang CN, Lee SD (2009) Post- to pre-overnight sleep systolic blood pressures are associated with sleep respiratory disturbance, pro-inflammatory state and metabolic situation in patients with sleep-disordered breathing. Sleep Med 10:720–725CrossRefPubMed
20.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
21.
go back to reference Faulx MD, Storfer-Isser A, Kirchner HL, Jenny NS, Tracy RP, Redline S (2007) Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 30:923–929PubMedCentralPubMed Faulx MD, Storfer-Isser A, Kirchner HL, Jenny NS, Tracy RP, Redline S (2007) Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 30:923–929PubMedCentralPubMed
22.
go back to reference Casserly LF, Chow N, Ali S, Gottlieb DJ, Epstein LJ, Kaufman JS (2001) Proteinuria in obstructive sleep apnea. Kidney Int 60:1484–1489CrossRefPubMed Casserly LF, Chow N, Ali S, Gottlieb DJ, Epstein LJ, Kaufman JS (2001) Proteinuria in obstructive sleep apnea. Kidney Int 60:1484–1489CrossRefPubMed
23.
go back to reference WHO expert consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef WHO expert consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef
24.
go back to reference Neusser MA, Lindenmeyer MT, Moll AG, Segerer S, Edenhofer I, Sen K, Stiehl DP, Kretzler M, Grone HJ, Schlondorff D, Cohen CD (2010) Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol 176:594–607PubMedCentralCrossRefPubMed Neusser MA, Lindenmeyer MT, Moll AG, Segerer S, Edenhofer I, Sen K, Stiehl DP, Kretzler M, Grone HJ, Schlondorff D, Cohen CD (2010) Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol 176:594–607PubMedCentralCrossRefPubMed
25.
go back to reference Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111CrossRefPubMed Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111CrossRefPubMed
26.
go back to reference Sim JJ, Rasgon SA, Kujubu DA, Kumar VA, Liu IL, Shi JM, Pham TT, Derose SF (2009) Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 135:710–716CrossRefPubMed Sim JJ, Rasgon SA, Kujubu DA, Kumar VA, Liu IL, Shi JM, Pham TT, Derose SF (2009) Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 135:710–716CrossRefPubMed
27.
go back to reference Tsioufis C, Thomopoulos C, Dimitriadis K, Amfilochiou A, Tsiachris D, Selima M, Petras D, Kallikazaros I, Stefanadis C (2008) Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis 52:285–293CrossRefPubMed Tsioufis C, Thomopoulos C, Dimitriadis K, Amfilochiou A, Tsiachris D, Selima M, Petras D, Kallikazaros I, Stefanadis C (2008) Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis 52:285–293CrossRefPubMed
28.
go back to reference Gruber A, Horwood F, Sithole J, Ali NJ, Idris I (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22PubMedCentralCrossRefPubMed Gruber A, Horwood F, Sithole J, Ali NJ, Idris I (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22PubMedCentralCrossRefPubMed
29.
go back to reference Mirrakhimov AE, Sooronbaev T, Mirrakhimov EM (2013) Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature. BMC Pulm Med 13:10PubMedCentralCrossRefPubMed Mirrakhimov AE, Sooronbaev T, Mirrakhimov EM (2013) Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature. BMC Pulm Med 13:10PubMedCentralCrossRefPubMed
30.
go back to reference Dursunoglu N (2009) Effects of menopause on obstructive sleep apnea. Tuberk Toraks 57:109–114PubMed Dursunoglu N (2009) Effects of menopause on obstructive sleep apnea. Tuberk Toraks 57:109–114PubMed
31.
go back to reference Ting H, Huang RJ, Lo HS, Chung AH, Chang SY, Wang L, Lee SP, Lee SD (2012) Vanished gender differences of cardiometabolic risk factors after matching the apnea hypopnea index at postmenopausal age. Gend Med 9:9–20CrossRefPubMed Ting H, Huang RJ, Lo HS, Chung AH, Chang SY, Wang L, Lee SP, Lee SD (2012) Vanished gender differences of cardiometabolic risk factors after matching the apnea hypopnea index at postmenopausal age. Gend Med 9:9–20CrossRefPubMed
Metadata
Title
Obstructive sleep apnea rather than diabetes or obesity associated with proteinuria in late mid-aged male workers: a decision tree analysis
Authors
Hua Ting
Cher-Ming Liou
Tung-Sheng Shih
Chih-Huan Wang
Shu-Yun Chang
Ai-Hui Chung
Jia-Fei Lee
Lee Wang
Ren-Jing Huang
Shin-Da Lee
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 4/2015
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-015-1132-z

Other articles of this Issue 4/2015

Sleep and Breathing 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.